NCT00984776View on ClinicalTrials.gov

Detection of Coronary Vulnerable Plaque With Contrast-enhanced Magnetic Resonance Imaging

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

February 28, 2009

Conditions
Coronary Artery DiseaseStable AnginaUnstable Angina
Interventions
OTHER

Contrast enhanced MRI with Gadofosveset

0.03 mmol/kg bodyweight of gadofosveset will only once be administered during MRI procedure via an intravenous catheter

Trial Locations (1)

6229 HX

Maastricht University Medical Center, Maastricht

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Maastricht University Medical Center

OTHER